Regeneron Pharmaceuticals, Inc. (REGN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 1.08B | 1.17B | 1.62B | 1.14B | 1.05B | 1.26B | 1.29B | 354M | 1.51B | 1.09B | 1.11B | 1.02B | 1.37B | 1.72B | 628.9M | 564.4M | 2.1B | 2.37B | 3.41B | 626.7M |
| Operating CF Margin % | 29.92% | 30.14% | 43.12% | 31.14% | 34.51% | 33.33% | 34.7% | 9.98% | 48.09% | 31.73% | 33.14% | 32.37% | 43.25% | 50.37% | 21.42% | 19.75% | 70.88% | 47.91% | 98.86% | 12.2% |
| Operating CF Growth % | 3.23% | -7.29% | 25.36% | 223.28% | -30.9% | 15.89% | 15.88% | -65.38% | 10.6% | -36.64% | 77.18% | 81.15% | -34.93% | -27.51% | -81.58% | -9.94% | 214.39% | 92.73% | 1442.35% | -33.57% |
| Net Income | 727.2M | 844.6M | 1.46B | 1.39B | 808.7M | 917.7M | 1.34B | 1.43B | 722M | 1.16B | 1.01B | 968.4M | 817.8M | 1.2B | 1.32B | 852.1M | 973.5M | 2.23B | 1.63B | 3.1B |
| Depreciation & Amortization | 123.2M | 145M | 136.7M | 135.1M | 126.9M | 126.4M | 121.7M | 120.7M | 114.1M | 113M | 105.4M | 103.1M | 99.5M | 100.1M | 92.6M | 74.4M | 74.3M | 74.5M | 73.2M | 71.1M |
| Stock-Based Compensation | 257.4M | 249.3M | 237M | 251.7M | 255.7M | 304.4M | 225.1M | 223.2M | 230.1M | 240.4M | 203.9M | 202M | 238.7M | 232M | 166.3M | 159.8M | 166.9M | 188.4M | 136.9M | 145.5M |
| Deferred Taxes | -96M | -232.5M | -278.6M | -135.2M | -139.1M | -280.2M | -168.6M | -118.1M | -190.4M | -286.3M | -125.7M | -209.3M | -216.5M | -279.7M | -85.7M | -156M | -225M | -205.9M | 7M | 41.7M |
| Other Non-Cash Items | 144.5M | 158.4M | -561.4M | -270.9M | -136.7M | 280.9M | -695.6M | -395.6M | 196.2M | -75.6M | 115.2M | 39.5M | 187.2M | 88.4M | -192.8M | 415.4M | 288.8M | 441.9M | 101.1M | -245.6M |
| Working Capital Changes | -77.4M | 5.9M | 625M | -227.9M | 129.6M | -86.4M | 468M | -908.5M | 440.5M | -61.4M | -192.3M | -81.3M | 240.9M | 382M | -667.2M | -781.3M | 823.2M | -355.4M | 1.46B | -2.48B |
| Change in Receivables | 1.2M | -51.2M | -80.3M | -28.2M | 657.8M | -117.8M | -388.9M | -494.1M | 446.8M | -82.7M | -463.5M | -2.7M | 210.1M | 219.6M | -386.9M | -322.4M | 1.2B | -584.5M | 1.54B | -2.83B |
| Change in Inventory | 26.6M | 2.1M | -82.6M | -42.5M | -152.3M | -117.7M | -164.4M | -181.8M | -155.8M | -47.3M | -77.2M | -100.4M | -46.8M | -144.3M | -223.5M | -240.1M | -88.6M | -163.7M | -109.1M | 31.3M |
| Change in Payables | 107.7M | -24.7M | 759.2M | 216.4M | -214.1M | 225.6M | 194.4M | 204.6M | 110.5M | 25.6M | 303.1M | 39.7M | 119M | 347.6M | -160.3M | -75.3M | -250.4M | 365.7M | 76.7M | 458.4M |
| Cash from Investing | -428.9M | 220.3M | -402.9M | -1.09B | 647.5M | 350.6M | -574.4M | -557.2M | -1.69B | -66.2M | -496.3M | -2.39B | -235.7M | -1.86B | 192.3M | -413.9M | -1.71B | -2.01B | -2.44B | 125.8M |
| Capital Expenditures | -230.6M | -290.7M | -244.7M | -406.8M | -271.5M | -267M | -183.6M | -210.9M | -161.8M | -313.5M | -176M | -113M | -178.2M | -152.2M | -142.5M | -153.6M | -141.8M | -154.9M | -133.2M | -148.5M |
| CapEx % of Revenue | 6.4% | 7.48% | 6.52% | 11.07% | 8.96% | 7.05% | 4.93% | 5.95% | 5.14% | 9.13% | 5.23% | 3.58% | 5.64% | 4.46% | 4.85% | 5.38% | 4.78% | 3.13% | 3.86% | 2.89% |
| Acquisitions | 0 | -300K | -3M | 0 | 0 | -11.5M | -20.1M | 15.1M | 0 | -3.8M | 199.9M | 133.9M | 100.9M | 1.62B | -1.26B | -230.3M | 1.56B | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -48.9M | 0 | 0 | 0 | 0 | 0 | -38.2M | 0 | 0 | 0 | -274.9M | -154.8M | -201.8M | -1.72B | 334.8M | 0 | -1.56B | 0 | 0 | 0 |
| Cash from Financing | -802.2M | -780.1M | -717.9M | -1.13B | -1.09B | -1.14B | -634M | -478.1M | 47.1M | -446.1M | -407.3M | -614.2M | -322.5M | -247.6M | -725M | -101.1M | 64.7M | -906.6M | 385.4M | -118.2M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -704.4M | -687.4M | -626.7M | -1.04B | -985.1M | -1.14B | -480.4M | -478.1M | 390.8M | 12M | -277.9M | -598.1M | -225.5M | -58.5M | -616.1M | -52.2M | 163.5M | -324.2M | 655M | -92M |
| Dividends Paid | -97.8M | -92.7M | -91.2M | -92.6M | -93.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -867.5M | -1.19B | -667M | -1.07B | -1.05B | -1.23B | -735.1M | -915.7M | -291.3M | -747.1M | -675.9M | -704.9M | -807.7M | -620.2M | -1.04B | -407.9M | -456.9M | -1.45B | -436M | -331.4M |
| Other Financing | 0 | 0 | 0 | 0 | -10.3M | 0 | -153.6M | 0 | -343.7M | -458.1M | -129.4M | -16.1M | -97M | -189.1M | -108.9M | -48.9M | -98.8M | -582.4M | -269.6M | -26.2M |
| Net Change in Cash | -153.1M | 610.6M | 497.5M | -1.08B | 604M | 477.2M | 83.6M | -681.6M | -128M | 577.6M | 210.5M | -1.98B | 809.4M | -385.4M | 96.2M | 49.4M | 461.1M | -546.8M | 1.36B | 634.3M |
| Free Cash Flow | 848.3M | 922M | 1.42B | 967.6M | 773.6M | 995.8M | 1.11B | 143.1M | 1.35B | 776.2M | 938.3M | 909.4M | 1.19B | 1.57B | 486.4M | 410.8M | 1.96B | 2.22B | 3.28B | 478.2M |
| FCF Margin % | 23.53% | 23.74% | 37.75% | 26.32% | 25.54% | 26.28% | 29.77% | 4.03% | 42.95% | 22.6% | 27.9% | 28.8% | 37.61% | 45.91% | 16.57% | 14.38% | 66.1% | 44.78% | 95.01% | 9.31% |
| FCF Growth % | 9.66% | -7.41% | 27.96% | 576.17% | -42.73% | 28.29% | 18.04% | -84.26% | 13.56% | -50.49% | 92.91% | 121.37% | -39.31% | -29.31% | -85.17% | -14.09% | 254.28% | 107.33% | 905.01% | -41.22% |
| FCF per Share | 7.88 | 8.58 | 13.22 | 8.91 | 6.96 | 8.75 | 9.53 | 1.24 | 11.74 | 6.82 | 8.27 | 7.98 | 10.43 | 13.75 | 4.31 | 3.60 | 17.33 | 19.59 | 28.80 | 4.32 |
| FCF Conversion (FCF/Net Income) | 1.48x | 1.39x | 1.11x | 0.82x | 1.29x | 1.38x | 0.96x | 0.25x | 2.09x | 0.94x | 1.11x | 1.06x | 1.67x | 1.44x | 0.48x | 0.66x | 2.16x | 1.06x | 2.09x | 0.20x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |